1 year return (CAGR)
98.02%
Ovid Therapeutics Inc Exchange (NASDAQ, USD)
OVID
2.50
-0.07 (-2.92%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-13.46%
5 year return (CAGR)
-6.28%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
487.27M
Price/Sales
307.81
Ent value
498.02M
Price/Book
2.32
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-29.81%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.54 |
| Daily high | 2.54 |
| Daily low | 2.40 |
| Daily Volume | 1.53M |
| All-time high | 15.00 |
| 1y analyst estimate | 5.69 |
| Beta | 0.25 |
| EPS (TTM) | -0.47 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 16 Mar 2026 |
Downside potential
Loading...
Downside potential data
| OVID | S&P500 | |
| Current price drop from All-time high | -83.37% | -1.38% |
| Highest price drop | -98.30% | -56.47% |
| Date of highest drop | 10 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -75.30% | -10.68% |
| Avg time to new high | 262 days | 12 days |
| Max time to new high | 2350 days | 1805 days |
News
